Cocrystal Pharma (COCP) EBITDA (2010 - 2026)
Cocrystal Pharma (COCP) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Cocrystal Pharma (COCP) EBITDA is -$8.97M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Cocrystal Pharma (COCP) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -43.73% |
| 3 Years TTM | -39.02% |
| 5 Years TTM | -2.50% |
| 10 Years TTM | -16.87% |
Annual EBITDA change of Cocrystal Pharma (COCP)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.34M | -73.85% |
| 2025 | -$8.95M | -49.58% |
| 2024 | -$18M | -3.38% |
| 2023 | -$18M | -52.46% |
| 2022 | -$39M | +175.41% |
| 2021 | -$14M | +48.78% |
| 2020 | -$9.43M | -80.48% |
| 2019 | -$48M | -23.16% |
| 2018 | -$63M | +670.47% |
| 2017 | -$8.16M | -92.27% |
| 2016 | -$106M | +96.47% |
| 2015 | -$54M | +860.00% |
| 2014 | -$5.60M | +45.83% |
| 2013 | -$3.84M | +59.34% |
| 2012 | -$2.41M | -28.27% |
| 2011 | -$3.36M | -940.00% |
| 2010 | $400K | N/A |
Comparison Cocrystal Pharma (COCP) five years EBITDA CAGR with competitors
Cocrystal Pharma (COCP) five years EBITDA CAGR is -2.51%.